ClavystBio
Finance · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Cintech Iv Singapore Science Park 79 Sci...Website
www.clavystbio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
2
About ClavystBio
ClavystBio is a life sciences investor and venture builder focused on translating scientific breakthroughs into health impacts. The company fosters the creation and growth of global companies through active incubation and investment. ClavystBio also forges public and private partnerships to accelerate talent development and commercialization. Their mission is to back great science and enable novel solutions in the life sciences sector.Explore more
ClavystBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ClavystBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ClavystBio has new funding data
Check out if ClavystBio is spiking on competitors!
Earning: See what the market has to say on ClavystBio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ClavystBio
ClavystBio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ClavystBio had a recent Job posting/layoffs
Check if ClavystBio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when ClavystBio launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
ClavystBio is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
ClavystBio is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about ClavystBio.
ClavystBio Tech Stack
A closer look at the technologies used by ClavystBio
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
ClavystBio News & Media
Respiree Closes US$11.6M Series A Financing Round Led by We Venture Capital and ClavystBio
HOUSTON and SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, announced the successful closing of a US$11.6 million Series A financing round led by We Venture Capital and ClavystBio. The round also had participation from Adaptive Capital Partners, conversion of note securities from Mayo Clinic’s Mayo Foundation for Medical Research and from existing investorClavystBio and A*STAR Partner to Grow MedTech Ventures in Singapore
SINGAPORE, June 10, 2025 /PRNewswire/ -- ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to create and grow MedTech ventures in Singapore. This partnership will support venture creation, product development, and commercialisation by bringing together ClavystBio and two national initiatives hosted by A*STAR — MedTLightstone Ventures, Temasek's ClavystBio co-lead Allay Therapeutics' US$57.5 million ...
[SINGAPORE] United States-based biotechnology company Allay Therapeutics on Thursday (Jun 5) announced it has raised US$57.5 million in a Series D financing round, co-led by biotech venture capital (VC) firm Lightstone Ventures and ClavystBio, a Temasek-linked life sciences venture builder.Allay Therapeutics Announces $57.5M Series D Financing and Venture Debt Line ... - Business Wire
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recup...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ClavystBio
Sign Up For FreeTo access detailed company insights
ClavystBio is a life sciences investor and venture builder focused on translating scientific breakthroughs into health impacts. The company fosters the creation and growth of global companies through active incubation and investment. ClavystBio also forges public and private partnerships to accelerate talent development and commercialization. Their... Read More
